Vnitr Lek 2026, 72(5):E27-E33 | DOI: 10.36290/vnl.2026.065

Giant cell arteritis with a mixed cranial and large-vessel phenotype presenting with atypical retroauricular headache and fever of unknown origin

Marcel Pavlík1, Oliver Kuchař1, Róbert Novotný2
1 Interní klinika Fakultní nemocnice Bulovka a 3. LF UK, Praha
2 Chirurgická klinika 3. LF UK a Fakultní nemocnice Královské Vinohrady, Praha

Giant cell arteritis is the most common primary large-vessel vasculitis affecting individuals older than 50 years. The classical cranial form is typically associated with temporal headache, jaw claudication, scalp tenderness, visual disturbances, and the risk of irreversible vision loss. However, the disease may also present as fever of unknown origin accompanied by a marked systemic inflammatory response without typical temporal artery involvement, leading to substantial diagnostic delay. We present the case of a 62-year-old woman with an approximately two-month history of right-sided retroauricular and occipital headache, daily febrile episodes, C-reactive protein levels repeatedly exceeding 100 mg/L, erythrocyte sedimentation rate above 100 mm/h, normocytic anemia, and reactive thrombocytosis. Repeated courses of antibiotic therapy were ineffective. Extensive infectious, otorhinolaryngological, neurological, and cardiological investigations, including brain CT and CT angiography, echocardiography, and basic oncological screening, failed to identify the cause of her symptoms. Ultrasonography of the temporal arteries did not demonstrate the characteristic halo sign, and temporal artery biopsy showed no histopathological evidence of vasculitis. During the diagnostic workup, the patient developed unilateral visual impairment of the right eye with visual field defects and findings consistent with ischemic optic neuropathy. After exclusion of the major infectious differential diagnoses, systemic glucocorticoid therapy was initiated immediately because of a strong clinical suspicion of giant cell arteritis. Subsequent ^18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) revealed active large-vessel vasculitis with diffuse increased FDG uptake in the aortic wall and its major branches, most prominently in both subclavian arteries, without evidence of malignancy or an infectious focus. This case illustrates giant cell arteritis with a mixed cranial and large-vessel phenotype, in which extracranial involvement predominated in extent and imaging conspicuity, whereas cranial ischemic manifestations were clinically decisive. It also demonstrates that neither a negative temporal artery ultrasound examination nor a negative temporal artery biopsy excludes the diagnosis. In patients older than 50 years presenting with fever of unknown origin, newly developed headache, markedly elevated inflammatory markers, and ischemic ocular symptoms, FDG PET/CT may provide decisive diagnostic information and substantially contribute to establishing the correct diagnosis.

Keywords: giant cell arteritis, large-vessel vasculitis, fever of unknown origin, FDG PET/CT, ischemic optic neuropathy, temporal arteritis.

Accepted: August 20, 2026; Published: August 27, 2026  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pavlík M, Kuchař O, Novotný R. Giant cell arteritis with a mixed cranial and large-vessel phenotype presenting with atypical retroauricular headache and fever of unknown origin. Vnitr Lek. 2026;72(5):E27-33. doi: 10.36290/vnl.2026.065.
Download citation

References

  1. Petersdorf RG, Beeson PB. Fever of unexplained origin: report on 100 cases. Medicine (Baltimore). 1961;40:1-30. Go to original source... Go to PubMed...
  2. Durack DT, Street AC. Fever of unknown origin: reexamined and redefined. Curr Clin Top Infect Dis. 1991;11:35-51.
  3. Wright WF, Auwaerter PG. Fever and fever of unknown origin: review, recent advances, and lingering dogma. Open Forum Infect Dis. 2020;7(5):ofaa132. Go to original source...
  4. Ferda J, Ferdová E, Záhlava J. Fever of unknown origin: a value of 18 F-FDG-PET/CT with integrated full diagnostic isotropic CT imaging. Eur J Radiol. 2010;73(3):518-525. Go to original source... Go to PubMed...
  5. Rohan T, Hložanka P, Dostál M, et al. Significance of F-18 FDG PET/MRI in the search for the etiology of inflammation of unclear origin and fever of unknown origin. Eur J Radiol. 2024;171:111281. Go to original source... Go to PubMed...
  6. Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. Lancet. 2008;372(9634):234-245. Go to original source... Go to PubMed...
  7. Weyand CM, Goronzy JJ. Giant-cell arteritis and polymyalgia rheumatica. N Engl J Med. 2014;371(1):50-57. Go to original source... Go to PubMed...
  8. Ponte C, Grayson PC, Robson JC, et al. 2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis. Ann Rheum Dis. 2022;81(12):1647-1653. Go to original source... Go to PubMed...
  9. Dejaco C, Ramiro S, Bond M, et al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update. Ann Rheum Dis. 2024;83(6):741-751. Go to original source... Go to PubMed...
  10. Hellmich B, Agueda A, Monti S, et al. 2018 Update of the EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis. 2020;79(1):19-30. Go to original source... Go to PubMed...
  11. Maz M, Chung SA, Abril A, et al. 2021 American College of Rheumatology/Vasculitis Foundation guideline for the management of giant cell arteritis and Takayasu arteritis. Arthritis Rheumatol. 2021;73(8):1349-1365. Go to original source... Go to PubMed...
  12. Narváez J, Nolla JM, Valverde-García J, et al. Usefulness of 18 F-FDG PET-CT for assessing large-vessel involvement in patients with suspected giant cell arteritis and negative temporal artery biopsy. Arthritis Res Ther. 2024;26:13. Go to original source...
  13. Rehák Z, Fojtík Z, Staníček J, Bolčák K, Frysáková L. 18 F-FDG PET v diagnostice vaskulitid velkých cév. Vnitr Lek. 2006;52(11):1037-1044.
  14. Rehák Z, Szturz P, Křen L, Fojtík Z, Staníček J. Upsampling from aorta and aortic branches: PET/CT hybrid imaging identified 18 F-FDG hypermetabolism in inflamed temporal and occipital arteries. Clin Nucl Med. 2014;39(1):e84-e86. Go to original source... Go to PubMed...
  15. Stone JH, Tuckwell K, Dimonaco S, et al. Trial of tocilizumab in giant-cell arteritis. N Engl J Med. 2017;377(4):317-328. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.